The results showed that the VEGF-A protein significantly diminished the regorafenib-inhibited cell viability, and the transient knockdown of VEGF-A by siRNA effectively sensitized HCC cells to regorafenib (Figure 2C,D). The gene discussed is VEGFA; the disease is hepatocellular carcinoma.